If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
If and I say if there was a placing then why is it that TB gets the opportunity to take part and no other shareholders? If he has, and we don’t know it is him, has manipulated the sp why can’t we all prosper from a placing?
Maybe we should make TB an offer for his shares as he doesn’t seem to value them that highly at the moment. If we all clubbed together and offered him say 3p a share what do we think his response would be.
Just thinking aloud here but only own 23% of the company and seems to be the only one making a profit whereas our money seems to be dropping
Thanks
If somebody keeps selling then where are those share going? Somebody must be accumulating.
Are we due a RNS if either TB or FAB?
We are due the paediatric rare drug update any day. If that is good news how low could the sp drop after that if it follows the same pattern?
Thanks
BB
We could get an offer from GEHC or Bayer at say 50p a share and the sp would still drop.
It is just so predictable whenever we get a RNS saying anything good that the sp will fall.
Anyway it is the weekend, have a good few day everyone
Thanks
As per normal a great update
Somebody sells quarter of a million shares and we see no increase in the sp.
At least it hasn’t gone down (yet)
What’s the odds we get a RNS with a TR1 later today or Monday?
Keep positive and believe in IB and it’s the work.
Thanks
If it was FAB selling shouldn’t they have gone below 3% by now. Wouldn’t that involve a RNS to confirm they are under this threshold. The last RNS was the same morning as the TR1 was sorted so a bit unusual for a delay issuing one if that was the case.
The buying and selling of the same value is the bit that interests me. One person swapping shares with another?
RNS from Mike or a RNS from IQAI which will come first?
Thanks
Interestingly saying that about the sells but if you look there seems to a corresponding buy for the same amount.
£2004 sell £1996 buy
£2504 sell £2496 buy
So it seems to me somebody is using a broker with a £4 fee and possibly swapping shares from one person to another
So FAB selling and somebody else in the family buying?
Just a thought
Thanks
BB
Two ways of looking at their mcap
Why are we so low relatively compared to them?
And
It seems we don’t get the voucher until the drug is fully approved by the FDA, so no $100m any time soon
Let’s hope the EAP is a quicker way to market and the promised land.
Thanks
Onceaday
So my reading is it did well but GBM Agile not happy so dropped it from the program but will not say why?
The trials seem to still be continuing with phase 2 results due any day.
All a bit strange but shows nothing is a given in this area of research
Thanks
Let’s hope we don’t get a sharp drop if we get PRDD.
The share price here keeps going lower hopefully we get RNS soon stating if somebody is buying or selling?
Regarding the 60 days, I thought we did the application just in time so that the 60 days does apply in this case. So we are overdue but Mike did say middle of Q1, I thought, so I assumed middle of February. I can’t find a list on the FDA website so can’t keep checking.
Will just have to keep waiting
Thanks
This company seems to be ahead of IQAI by a few years in development of a similar drug. Unfortunately their mcap is only $9m
We could be in for a long wait for IQAi to shoot up in value if this is a typical example of PRD and ODD
https://www.prnewswire.com/news-releases/us-fda-awards-rare-pediatric-disease-designation-rpdd-to-paxalisib-for-atrt-a-rare-form-of-childhood-brain-cancer-301581006.html
Thanks
An interesting read on what drugs the FDA approved last year whilst we wait for any update from IQAI/IB some of you may be interested in.
https://www.fda.gov/news-events/fda-voices/fda-approves-many-new-drugs-2023-will-benefit-patients-and-consumers
Thanks
We need to separate IQAI and IB
We all talk about the issues people see with IQAI but IB are at the forefront of what they do. It will only be a matter of time before a larger company makes an offer that forces IQAI’s hand in my opinion.
IB are doing everything they can via conferences, webinars etc. They are targeting their customers not investors which is what we all want them to do. They are seemingly being guided by the FDA through the drug trial. Again this will not be going unnoticed by the big boys.
IQAI seem to be strengthening their hold on the company in their own way so as to maximise their return. A good outcome for them will mean a good outcome for all of us I would say. Keep personalities out of the equation and look at the fact in my opinion.
Have a good weekend everybody
Thanks